Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer crawled time : 22:17 save search
POAI Subsidiary Helomics Continues Progress Towards Goal of Developing an AI-Driven Predictive Model of Ovarian Cancer
Published: 2020-03-31 (Crawled : 22:17) - globenewswire.com
POAI | $1.18 22K
|
Health Technology
|
| O: -6.59%
H: 12.35%
C: -7.34%
cancer ovarian cancer
Predictive Oncology’s TumorGenesis Division Secures First Commercial Sale of its Novel Ovarian Cancer Cell Media
Published: 2020-06-18 (Crawled : 22:17) - globenewswire.com
POAI | $1.18 22K
|
Health Technology
|
| O: 6.98%
H: 13.04%
C: 8.15%
cancer ovarian cancer commercialization
Predictive Oncology Secures License for an Additional 71 Unique Ovarian Cancer Cell Lines from Ximbio, Cancer Research UK’s Premier Reagents Distributor
Published: 2020-09-22 (Crawled : 22:17) - globenewswire.com
POAI | $1.18 22K
|
Health Technology
|
| O: 25.34%
H: 8.49%
C: -6.92%
license cancer research ovarian cancer
Gainers vs Losers
| 89% | 11% |
Top 10 Gainers
MTTR | News M | $4.65 167.24% 9.8M
|
AGBA | $2.355 88.4% 34M
|
Finance
EDBL | News | $6.75 79.52% 1.5M
|
CZOO | $8.77 75.75% 11M
|
VNRX | $0.84 40.0% 2.6M
|
Health Technology
OPRT | News | $3.01 33.78% 6.8M
|
Finance
MLEC | $1.81 29.29% 2M
|
n/a
CMAX | $4.12 28.35% 65K
|
Manufacturing
MTC | $2.0 28.21% 1.7M
|
Technology Services
PEGY | $0.0586 27.95% 130M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.